Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53

Genes and Development

Volumn 11, Issue 6, 1997, Pages 714-725

  Lundgren, Karen ^a,c   Montes De Oca Luna, Roberto ^b   McNeill, Yvette Boddie ^a   Emerick, Elena P ^a,d   Spencer, Ben ^a   Barfield, Cynthia Rahn ^a   Lozano, Guillermina ^b   Rosenberg, Michael P ^a   Finlay, Cathy A ^a  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c AGOURON PHARMACEUTICALS INC   (United States)

^d Research Triangle Institute   (United States)

Author keywords

cell cycle; mdm2; p53; transgenic mice; tumor

Indexed keywords

CELL PROTEIN; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CARCINOGENESIS; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALIA; BOVINAE; MUS MUSCULUS;

EID: 14444281159     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.6.714     Document Type: Article

References (53)

1. Amundadottir, L.T., G. Merlino, and R.B. Dickson. 1996. Transgenic mouse models of breast cancer. Breast Cancer Res. Treat. 39: 119-135.
2. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461-468.
3. Bortner, D.M. and M.P. Rosenberg. 1995. Overexpression of cyclin A in the mammary glands of transgcnic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth & Differ. 6: 1579-1589.
4. Cahilly-Snyder, L., T. Yang-Feng, U. Francke, and D.L. George. 1987. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat. Cell Mol. Genet. 13: 235-244.
5. Cardiff, R.D. and W.J. Muller. 1993. Transgenic mouse models of mammary tumorigenesis. Cancer Surveys 16: 97-113.
6. Cardiff, R.D. and R.J. Munn. 1995. Comparative pathology of mammary tumorigenesis in transgenic mice. Cancer Lett. 90: 13-19.
7. Chen, J., V. Marechal, and A.J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13: 4107-4114.
8. Chen, J., J. Lin, and A.J. Levine. 1995. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1: 142-152.
9. 1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16: 2445-2452.
10. Cohen, C. 1996. Image cytometric analysis in pathology. Hum. Pathol 27: 482-493.
11. Cordon-Cardo, C., E. Latres, M. Drobnjak, M.R. Oliva, D. Pollack, J.M. Woodruff, V. Marechal, J. Chen, M.F. Brennan, and A.J. Levine. 1994. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 54: 794-799.
12. DeGregori, J., T. Kowalik, and J.R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215-4224.
13. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, Jr., J.S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221.
14. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis 11: 2245-2251.
15. Eldridge, S.R., B.E. Butterworth, and T.L. Goldsworthy. 1993. Proliferating cell nuclear antigen: A marker for hepatocellular proliferation in rodents. Environ. Health Perspect. (Suppl 5) 101: 211-218.
16. Fakharzadeh, S.S., S.P. Trusko, and D.L. George. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565-1569.
17. Finlay, C.A. 1993. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306.
18. Foley, J.F., D.R. Dietrich, J.A. Swenberg, and R.R. Maronpot. 1991. Detection and evaluation of proliferating cell nuclear antigen (PCNA) in rat tissue by an improved immunohistochemical procedure. J. Histotechnol. 14: 237-241.
19. Fontana, X., P. Ferrari, M. Abbes, J. Monticelli, M. Namer, and F. Bussiere. 1994. Study of mdm2 gene amplification in primary breast tumors. Bull. Cancer 81: 587-592.
20. Harris, S., M. McClenaghan, J.P. Simons, S. Ali, and A.J. Clark. 1991. Developmental regulation of the sheep β-lactoglobulin gene in the mammary gland of transgenic mice. Dev. Genet. 12: 299-307.
21. Haupt, Y., Y. Barak, and M. Oren. 1996. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15: 1596-1606.
22. Hiebert, S.W., G. Packham, D.K. Strom, R. Haffner, M. Oren, G. Zambetti, and J.L. Cleveland. 1995. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15: 6864-6874.
23. Jacks, T., L. Remington, B.O. Williams, E.M. Schmitt, S. Halachmi, R.T. Bronson, and R.A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
24. Jones, S.N., A.E. Roe, L.A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in mdm2-deficient mice by absence of p53. Nature 378: 206-208.
25. Juven, T., Y. Barak, A. Zauberman, D.L. George, and M. Oren. 1993. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8: 3411-3416.
26. Kim, S.H., K.A. Roth, A.R. Moser, and J.I. Gordon. 1993. Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J. Cell Biol. 123: 877-893.
27. Kucera, G.T., D.M. Bortner, and M.P. Rosenberg. 1996. Overexpression of an agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants. Dev. Biol. 173: 162-173.
28. Ladanyi, M., C. Cha, R. Lewis, S.C. Jhanwar, A.G. Huvos, and J.H. Healey. 1993. MDM2. gene amplification in metastatic osteosarcoma. Cancer Res. 53: 16-18.
29. Leach, F.S., T. Tokino, P. Meltzer, M. Burrell, J.D. Oliner, S. Smith, D.E. Hill, D. Sidransky, K.W. Kinzler, and B. Vogelstein. 1993. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53: 2231-2234.
30. Li, M., J. Hu, K. Heermeier, L. Hennighausen, and P.A. Furth. 1996. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: Induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth &. Differ. 7: 3-11.
31. Marchetti, A., F. Buttitta, S. Girlando, P. Dalla Palma, S. Pellegrini, P. Fina, C. Doglioni, G. Bevilacqua, and M. Barbareschi. 1995. mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J. Pathol. 175: 31-38.
32. Marchevsky, A., T. Tolmachoff, and S. Lee. 1996. Quality assurance issues in DNA image cytometry. Cytometry 26: 101-107.
33. Martin, K., D. Trouche, C. Hagemeier, T.S. Sorensen, N.B. La Thangue, and T. Kouzarides. 1995. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375: 691-694.
34. McCann, A.H., A. Kirley, D.N. Carney, N. Corbally, H.M. Magee, G. Keating, and P.A. Dervan. 1995. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. Br. J. Cancer 71: 981-985.
35. Momand, J., G.P. Zambetti, D.C. Olson, D. George, and A.J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
36. Montes de Oca Luna, R., D.S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
37. Montes de Oca Luna, R., A.D. Tabor, H. Eberspaecher, D.L. Hulboy, L.L. Worth, M.S. Colman, C.A. Finlay, and G. Lozano. 1996. The organization and expression of the mdm2 gene. Genomics 33: 352-357.
38. Muller, W.J., E. Sinn, P.K. Pattengale, R. Wallace and P. Leder. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105-115.
39. Oliner, J.D., K.W. Kinzler, P.S. Meltzer, D.L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83.
40. Oliner, J.D., J.A. Pietenpol, S. Thiagalingam, J. Gyuris, K.W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860.
41. Osborn, L., M.P. Rosenberg, S.A. Keller, and M.H. Meisler. 1987. Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. Mol. Cell. Biol. 7: 326-334.
42. Qin, X.-Q., D.M. Livingston, W.G. Kaelin, Jr., and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
43. Quesnel, B., C. Preudhomme, J. Fournier, P. Fenaux, and J.P. Peyrat. 1994. MDM2 gene amplification in human breast cancer. Eur. J. Cancer 30a: 982-984.
44. Reifenberger, G., L. Liu, K. Ichimura, E.E. Schmidt, and V.P. Collins. 1993. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53: 2736-2739.
45. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
46. Schulte, E. and D. Wittekind. 1989. Standardization of the Feulgen-Schiff technique. Histochemistry 91: 321-331.
47. Shan, B. and W.H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166-8173.
48. Sheikh, M.S., Z.M. Shao, A. Hussain, and J.A. Fontana. 1993. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res. 53: 3226-3228.
49. Tsukamoto, A.S., R. Grosschedl, R.C. Gusman, T. Parslow, and H.E. Varmus. 1988. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625.
50. Wang, T.C., R.D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E.V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671.
51. Wu, X. and A.J. Levine. 1994. P53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. 91: 3602-3606.
52. Wu, X., J.H. Bayle, D. Olson, and A.J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes & Dev. 7: 1126-1132.
53. Xiao, Z.X., J. Chen, A.J. Levine, N. Modjtahedi, J. Xing, W.R. Sellers, and D.M. Livingston. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698.